Homocysteine and folate concentrations in blood from patients treated with hemodialysis

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2414-2418

  Tamura, Tsunenobu ^a   Johnston, Kelley E ^a   Bergman, Suzanne M ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Center for Palliative Care   (United States)

Author keywords

Cardiovascular disease; ESRD; Folic acid supplementation

Indexed keywords

ERYTHROPOIETIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FLUOROMETRY; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; SUPPLEMENTATION;

EID: 0030357955     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Clarke R, Daly L, Robinson K, et al.: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
2. Selhub J, Jacques PF, Bostom AG, et al.: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286-291.
3. Robins AJ, Milewczyk BK, Booth EM, Mallick NP: Plasma amino acid abnormalities in chronic renal failure. Clin Chim Acta 1972;42:215-217.
4. Wilcken DEL, Gupta VJ: Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979;9:301-307.
5. Wilcken DEL, Gupta VJ, Betts AK: Homocysteine in the plasma of renal transplant receipients: Effect of cofactors for methionine metabolism. Clin Sci 1981;61:743-749.
6. Kang S-S, Wong PWK, Bidani A, Milanez S: Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis. Clin Sci 1983;65:335-336.
7. Laidlaw SA, Smolin LA, Davidson WD, Kopple JD: Sulfur amino acids in maintenance hemodialysis patients. Kidney Int 1987;32[Suppl 22]:S191-S196.
8. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metab Clin Exp Ther 1988; 37:697-701.
9. Soria C, Chadefaux B, Coude M, Gaillard O, Kamoun P: Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 1990;36:2137-2138.
10. Chauveau P, Chadefaux B, Cloude M, et al.: Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab 1992;18: 196-198.
11. Chauveau P, Chadefaux B, Cloude M, et al.: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;43[Suppl 41]: S72-S77.
12. Arnadottir M, Brattström L, Simonsen O, et al.: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993;40:236-240.
13. Massy ZA, Chadefaux-Vekemans B, Chevalier A, et al.: Hyperhomocysteinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994;9:1103-1108.
14. Janssen MJFM, van den Berg M, van Guldener C, Boers GHJ, Stehouwer CDA: Withdrawal of folic acid supplementation in maintenance hemodialysis patients. Clin Nephrol 1994;42:136-137.
15. Perna AF, Ingrosso D, De Santo NG, Galletti P, Zappia V: Mechanism of erythrocyte accumulation of methylation inhibitor S-adenocylhomocysteine in uremia. Kidney Int 1995;47:247-253.
16. Hultberg B, Andersson A, Arnadottir M: Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron 1995;70:62-67.
17. Bostom AG, Shemin D, Nadeau MR, et al.: Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis 1995;113:129-132.
18. Bostom AG, Shemin D, Lapane KL, et al.: Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 1995;114:93-103.
19. Guttormsen AB, Svarstad E, Ueland PM, Refsum H: Elimination of homocysteine from plasma in subjects with endstage renal failure. Irish J Med Sci 1995; 164[Suppl 15]:8-9.
20. Bostom AG, Shemin D, Lapane KL, et al.: High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 1996;49:147-152.
21. Livant EJ, Tamura T, Johnston KE, et al: Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis. J Nutr Biochem 1994;5: 504-508.
22. Stabler SP, Marcell PD, Podell ER, Allen RH: Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 1987;162:185-196.
23. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993;39:1764-1779.
24. Cornwell BAH, Morgan SL, Vaughn WH: Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromat 1993;617:136-139.
25. Tamura T. Microbiological assay of folates. In: Picciano MF, Stokstad ELR, Gregory JF III, eds. Folic Acid Metabolism in Health and Disease. Contemporary Issues in Clinical Nutrition, Vol. 13. New York: Wiley-Liss; 1990: 121-137.
26. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
27. Tamura T, Soong S-J, Sauberlich HE, Hatch KD, Cole P, Butterworth CE Jr: Evaluation of deoxyuridine suppression test by using whole blood samples from folic acid-supplemented subjects. Am J Clin Nutr 1990;51:80-86.
28. Ono K, Hisasue Y: Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy? Clin Nephrol 1992;38:290-292.
29. Westhuyzen J, Matherson K, Tracey R, Fleming SJ: Effect of withdrawal of folic acid supplementation in maintenance hemodialysis patients. Clin Nephrol 1993; 40:96-99.
30. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995;116:59-62.
31. Wilcken DEL, Wilcken B, Dudman NPB, Tyrrell PA: Homocystinuria - The effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 1983;309:448-453.